CD276 and cervical cancer: First, to confirm previous reports of a tumorigenic role for B7-H3 protein expression6,27, we used CRISPR/Cas9 to knockout CD276 (B7-H3) expression in HeLa cervical cancer cells (Supplemental Fig. 1).